• Above all, we make a difference.
  • Funding Opportunities

    At Susan G. Komen ®, we are committed to ending breast cancer forever by empowering people, energizing science to find the cures and ensuring quality care for all people, everywhere. Our Research Program is an essential driving force for achieving this mission.

    Komen has sustained a strong commitment to supporting research that will identify and deliver cures for breast cancer. This commitment has resulted in important progress that has contributed to many significant advances in breast cancer over the past 30 years. We began with a single grant for $28,000 in 1982. With increasing investments over time, now totaling over $800 million, Komen is the largest non-government funder of breast cancer research.

    Our research focus has evolved over the years. In the beginning we focused on understanding the basic biology of breast cancer. As we learn more about the factors that make cancer cells grow and spread, we are able to invest more in the translation of this knowledge into treatment, early detection and prevention, with the goal of supporting work that has significant potential to lead to reductions in incidence and mortality within the decade.

    As the global leader in the fight against breast cancer, we strive to identify the best science around the world. We are proud that we have funded research in the United States and 17 other countries. Applications are welcome from investigators anywhere across the globe.

    Funding Opportunities

    2014-15 (FY15) Requests for Applications

    Career Catalyst Research Grants (CCR)

    $450,000 combined direct and indirect costs; ($150,000 per year for up to 3 years)

    CCR Grants provide unique opportunities for scientists who have held faculty positions for no more than six years at the time of full application to achieve research independence. CCR grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer.

    There are 2 Research Focus Areas: Basic/Translational and Clinical.

     

    Career Catalyst Research Grants – Basic/Translational Research 

    This award mechanism is appropriate for both basic (i.e. Ph.D.) or clinical (i.e. M.D.) fellows proposing research projects that are laboratory- or field- based and do not meet Komen's definition of clinical research. Studies focusing on quality of life or survivorship issues are not appropriate for this mechanism. 
     

    Career Catalyst Research Grants – Clinical Research
    This award mechanism is appropriate for clinical (i.e. M.D.) fellows/faculty proposing clinical, patient-oriented research projects that involve direct interactions with human subjects/patients. This includes studies such as therapeutic interventions or clinical trials.

    Komen defines clinical research as hypothesis driven, patient-oriented research for which an investigator directly interacts with human subjects/patients, in conjunction with laboratory-based research, as appropriate. This includes studies such as therapeutic interventions or clinical trials.

     RFA Release Date: May 23, 2014
    Application system open date: May 23, 2014
    Pre-Application Submission deadline: July 17, 2014  

     

    Postdoctoral Fellowship Grants (PDF) 

    Up to $180,000 direct costs only; ($60,000 per year for 2 to 3 years)

    PDF Grants seek to attract and support promising scientists embarking on careers dedicated to breast cancer research who have no more than 3 years post-completion of their most recent clinical fellowship, 5 years post-completion of their most recent residency (for physicians), or 5 years post-completion of their most recent Ph.D. By providing funding to outstanding postdoctoral/postgraduate fellows under the guidance of a mentor, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research. PDF Grants provide support for research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer.

    There are 2 Research Focus Areas: Basic/Translational and Clinical

     

    Postdoctoral Fellowship Grants – Basic/Translational Research
    This grant mechanism is appropriate for both basic (i.e. Ph.D.) or clinical (i.e. M.D.) fellows proposing research projects that are laboratory- or field- based and do not meet Komen's definition of clinical research. Studies focusing on quality of life or survivorship issues are not appropriate for this mechanism.

    A separate PDF-Clinical Research RFA is available for clinical fellows proposing clinical research studies on breast cancer.

     

    Postdoctoral Fellowship Grants – Clinical Research
    This grant mechanism is appropriate for clinical (i.e. M.D.) fellows proposing clinical, patient-oriented research projects that involve direct interactions with human subjects/patients. This includes studies such as therapeutic interventions or clinical trials.

    Komen defines clinical research a hypothesis driven, patient-oriented research for which an investigator directly interacts with human subjects/patients, in conjunction with laboratory-based research as appropriate. This inculdes studies such as therapeutic interventions or clinical trials.

     

    RFA Release Date: May 23, 2014
    Application system open date: May 23, 2014
    Pre-Application Submission deadline: July 17, 2014  

     

    Graduate Training in Disparities Research (GTDR)  

    Up to $135,000 per year, direct costs only, for up to 3 years

    GTDR Grants (formerly Post-Baccalaureate Training in Disparities Research Grants, PBTDR) are intended to establish and/or to sustain a training program for a minimum of three graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups.

    RFA Release Date: May 23, 2014
    Application system open date: May 23, 2014
    Pre-Application Submission deadline: July 17, 2014  

     

    Resources for Funding Opportunities 

    For a list of grantwriting resources to help with preparing your application, please visit our Grantwriting Resources for Young Investigators page.

     Army of Women
    Researchers submitting project proposals to Susan G. Komen® that will utilize human studies are highly encouraged to access the Army of Women® to obtain volunteers. The Army of Women® is a program of the Dr. Susan Love Research Foundation. Founded in 2008, the goal is to accelerate breast cancer research by providing a link for researchers to engage dedicated volunteers who are willing to donate time, information, and biological samples to help understand the causes of breast cancer and prevent it. You should include costs for the Army of Women e-blast in your proposal, and we encourage you to notify the AOW staff of your proposal and obtain budget information from them (e-mail research@armyofwomen.org). For details about the Army of Women, please visit www.armyofwomen.org and review the “For Researchers” section.

    Komen Tissue Bank
    The Susan G. Komen Tissue Bank at the Indiana University Simon Cancer Center (KTB) is the only repository in the world for normal breast tissue and matched serum, plasma and DNA. It is a goal of the KTB to acquire biomolecules and tissue specimens from the entire continuum of breast development from puberty to menopause. The KTB collects the following types of samples: fresh frozen tissue; formalin-fixed paraffin-embedded (FFPE) tissue; blood products including whole blood, plasma, serum; and DNA from lymphocytes. These samples are available to investigators to conduct research which will provide insight into breast oncogenesis. Additionally, the KTB has created a virtual tissue bank which will be populated with data derived from research completed with KTB samples; other researchers from around the world will be able to access this data.

     

    The KTB invites researchers to take advantage of the available normal breast tissue to understand the biology of breast cancer. Komen is encouraging the use of this unique resource by inviting Applicants/PIs to include plans for utilizing tissues from the KTB in their grant applications. For more information, visit http://komentissuebank.iu.edu.

     

    Komen Review Process

    Susan G. Komen® utilizes a multi-step approach to application and review that requires submission of a pre-application and full application upon invitation only. Pre-applications are first administratively reviewed for eligibility, submission of required application materials, adherence to formatting requirements, and responsiveness to the RFA. Applications that do not meet eligibility, submission, formatting, or responsiveness requirements will be administratively withdrawn and WILL NOT undergo scientific review. 

    Each qualified pre-application is reviewed by a panel of three scientists with appropriate expertise and a patient advocate. Scientist and advocate reviewers assess the strengths and weaknesses of each application based on the defined review criteria defined in each RFA.
     

    Only Applicants with pre-applications deemed most meritorious and aligned with Komen's research mission will be invited to submit full applications. It is anticipated that full applications will be invited from approximately 20-25% of pre-application submitters.

    Applicants will be notified of pre-application review decisions via email. Once notifications are sent, Applicants will be granted access to reviewer comments. Applicants invited to submit a full application will then be granted access to the full application site.

    All institutions and industry partners must agree to adhere to Komen's Policies and Procedures for Research and Training Grants.
    Please see Appendix A for a detailed list of definitions and allowed Personnel for each grant mechanism.

    Questions?Contact the Komen Research Programs Help Desk at www.komen.org/researchhelpdesk